Products
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
BAYER AG
🇩🇪
Germany
Country
🇩🇪
Germany
Ownership
Public
Established
1863-08-01
Employees
99.7K
Market Cap
$30.1B
Website
http://www.bayer.com
Clinical Trials
Related News
Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)
Phase 3
Completed
Conditions
Macular Edema
Interventions
Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
Subscribe
First Posted Date
2016-06-30
Last Posted Date
2020-07-31
Lead Sponsor
Bayer
Target Recruit Count
463
Registration Number
NCT02818998
Subscribe
First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080
Phase 1
Completed
Conditions
Clinical Trials, Phase I as Topic
Interventions
Drug: BAY1817080
Drug: Placebo
Drug: Itraconazole
Subscribe
First Posted Date
2016-06-29
Last Posted Date
2017-09-06
Lead Sponsor
Bayer
Target Recruit Count
88
Registration Number
NCT02817100
Locations
🇩🇪
CRS Clinical Research Services Berlin GmbH, Berlin, Germany
Subscribe
Sun Protection Factor Assay (SPF Assay 19009)
Not Applicable
Completed
Conditions
Sunscreening Agents
Interventions
Drug: BAY987517
Subscribe
First Posted Date
2016-06-28
Last Posted Date
2018-12-13
Lead Sponsor
Bayer
Target Recruit Count
5
Registration Number
NCT02815228
Subscribe
Sun Protection Factor Assay
Not Applicable
Completed
Conditions
Sunscreening Agents
Interventions
Drug: BAY987517
Subscribe
First Posted Date
2016-06-28
Last Posted Date
2018-12-13
Lead Sponsor
Bayer
Target Recruit Count
5
Registration Number
NCT02815241
Subscribe
Sun Protection Factor Assay (SPF Assay 19008)
Not Applicable
Completed
Conditions
Sunscreening Agents
Interventions
Drug: BAY987517
Subscribe
First Posted Date
2016-06-28
Last Posted Date
2018-12-13
Lead Sponsor
Bayer
Target Recruit Count
5
Registration Number
NCT02815202
Subscribe
Study for Collection of Aflibercept Data in Routine Practice
Completed
Conditions
Eye Diseases
Interventions
Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
Subscribe
First Posted Date
2016-06-23
Last Posted Date
2019-07-02
Lead Sponsor
Bayer
Target Recruit Count
425
Registration Number
NCT02811692
Subscribe
Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases
Completed
Conditions
Prostatic Neoplasms, Castration-Resistant
Interventions
Drug: Radium-223 dichloride (Xofigo, BAY 88-8223)
Subscribe
First Posted Date
2016-06-17
Last Posted Date
2025-01-10
Lead Sponsor
Bayer
Target Recruit Count
334
Registration Number
NCT02803437
Subscribe
Test the Phototoxicity of Sunscreen Products
Not Applicable
Completed
Conditions
Sunscreen Agents
Interventions
Drug: SPF 50 Y65 110 (BAY987519)
Drug: SPF 50 Y51 002 (BAY987519)
Drug: SPF 15 V27 104 (BAY987519)
Drug: Sodium chloride [NaCl]
Subscribe
First Posted Date
2016-06-16
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
32
Registration Number
NCT02802930
Subscribe
To Assess the Safety of a Sunscreen Product
Not Applicable
Completed
Conditions
Sunscreening Agents
Interventions
Drug: SPF 50 Y65 110 (BAY 987516)
Subscribe
First Posted Date
2016-06-16
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
107
Registration Number
NCT02803320
Subscribe
18670 - Sun Protection Factor Assay
Not Applicable
Completed
Conditions
Sunscreening Agent
Interventions
Drug: Coppertone (BAY987518)
Subscribe
First Posted Date
2016-06-16
Last Posted Date
2018-12-13
Lead Sponsor
Bayer
Target Recruit Count
10
Registration Number
NCT02801929
Subscribe
Prev
1
56
57
58
59
60
163
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy